跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DIAPLEX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DIAPLEX
Authorized
STANDARD
DIAPLEX
NEPHRO-TECH, INC.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5088f58d2b927d96
Company
NEPHRO-TECH, INC.
Type
Standard
Approval Details
Approval Id
5088f58d2b927d96
Drug Approval Canada Name
DIAPLEX
Product Name
DIAPLEX
Status
Cancelled Post Market
Status Date
2004-07-23
Original Market Date
2002-07-10
Din
02244961
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
88:28.01*
Atc Original
A11EX VITAMIN B-COMPLEX, OTHER COMBINATIONS
Atc Name
a 11 ex
Aig Number
1045882001
Company Name
NEPHRO-TECH, INC.
Company Address
4627 Pawnee, Wellsville, Kansas, United States, 66092
Company Detail Path
/organization/nephro-tech-inc
Company Information
Pharmaceutical Company Name
NEPHRO-TECH, INC.
Country Name
United States
Province Name
堪萨斯州
City Name
堪萨斯州肖尼县
Address
6425 Nieman Rd
Website
http://www.nephrotech.com
Active Ingredients
BIOTIN
300 MCG
FOLIC ACID
0.8 MG
NICOTINAMIDE
20 MG
ASCORBIC ACID (ASCORBIC ACID)
60 MG
D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE)
10 MG
VITAMIN B2 (VITAMIN B2)
1.7 MG
VITAMIN B1 (VITAMIN B1)
1.5 MG
VITAMIN B12 (VITAMIN B12)
6 MCG
ZINC (ZINC OXIDE)
12.5 MG
VITAMIN B6 (VITAMIN B6)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5088f58d2b927d96
Type
Standard
Back to Health Canada Approvals